High humidity environment increases FBG by impairing the intestinal barrier
Open Access
- 27 August 2025
- journal article
- immunology
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1625609
Abstract
Introduction: Climate and environmental changes pose significant threats to human metabolic health; however, the specific effects of individual environmental factors on metabolic diseases remain poorly understood. This study aimed to investigate the impact of a high humidity environment (HH) on fasting blood glucose (FBG), intestinal barrier integrity, and gut microbiota composition.Methods: We analyzed clinical samples collected during HH exposure and performed a controlled male mouse experiment. FBG and hormone levels were assessed, and intestinal barrier integrity was evaluated using western blot and immunofluorescence staining. Gut microbiota composition was profiled via 16S rDNA sequencing. Mechanistic insights were obtained through fecal microbiota transplantation (FMT), Mendelian randomization (MR) analysis, and metabolomic profiling. An antibiotic cocktail (ABX) intervention was applied to determine the reversibility of HH-induced effects.Results: Clinical samples collected under HH conditions showed elevated FBG, increased glucagon (GC) levels, impaired intestinal barrier function, and decreased serum gamma-aminobutyric acid (GABA) concentrations. 16S rDNA sequencing revealed increased abundances of Alistipes, Parabacteroides, and Akkermansia. Metabolomic analysis demonstrated reduced serum GABA levels, which correlated with intestinal barrier disruption and activation of the MDP-NOD2 pathway in pancreatic β-cells. HH exposure also downregulated GAD67 expression, reducing GABA synthesis and leading to enhanced GC secretion from islet α-cells. FMT suggested that gut microbiota alterations mediated HH-induced FBG elevation. ABX treatment effectively reversed these metabolic and microbial changes.Discussion: Our findings demonstrate that a high humidity environment disrupts gut microbiota homeostasis, impairs the intestinal barrier, and reduces GABA synthesis in pancreatic β-cells, thereby promoting the development of type 2 diabetes mellitus (T2DM).Keywords
This publication has 42 references indexed in Scilit:
- Gut microbiota associated with appetite suppression in high-temperature and high-humidity environmentsEBioMedicine, 2023
- Microbiota dysbiosis in primary Sjögren’s syndrome and the ameliorative effect of hydroxychloroquineCell Reports, 2022
- Communications in the IPCC’s Sixth Assessment Report cycleClimatic Change, 2021
- The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brainArchives of Pharmacal Research, 2019
- Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectivesProtein & Cell, 2018
- Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4Cell Metabolism, 2017
- Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell NeogenesisCell, 2017
- Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor systemCell Metabolism, 2006
- Association of connexin36 with zonula occludens-1 in HeLa cells, ?TC-3 cells, pancreas, and adrenal glandHistochemistry and Cell Biology, 2000
- Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissuesComparative Biochemistry and Physiology Part A: Physiology, 1995